Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
57 /100
COMPONENT-LIMITED
Score updated Oct 28, 2026

EOCN — Galmed Pharmaceuticals Ltd. Dilution Risk Tracker

Track EOCN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EOCN — Get alerts when the score changes →

As of October 28, 2026, Galmed Pharmaceuticals Ltd. (EOCN) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Galmed Pharmaceuticals Ltd. has a market capitalization of $21.06M, 6.58M shares outstanding. Stored dilution-related fields include 173.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
25
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for EOCN.
🔔 Track EOCN — Get forecast alerts →

Market Data

Market Cap$21.06M
Shares Outstanding6.58M
FloatN/A
Cash$9.88M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore57/100DilutionWatch score record
Shares Outstanding6.58MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$21.06MMarket data cache
Cash Runway20.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants173.3KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest7.5K
Days to Cover1.0
% of FloatN/A
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2016-03-22
Full SEC filing analysis available with free account →

Recent News

Factual EOCN Dilution Snapshot

Galmed Pharmaceuticals Ltd. (EOCN) has a DilutionScore of 57/100, rated High dilution risk. Score date: October 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

EOCN's DilutionScore is currently 57/100 (High risk), with 1 score change tracked over 90 days. The score improved from 56/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 28, 202657/100HIGH31 days
Jul 31 – Sep 27, 202656/100HIGH59 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track EOCN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment EOCN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking EOCN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,567+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note